Drug Development

Articles

The divestment of the pharma and food ingredients business is in line with Ferrer’s new strategy to focus on the core business of branded pharmaceuticals.

Riverside Acquires Pharma and Food Ingredients Biz from Ferrer

Cambrex reports that the acquisition by the investment group will facilitate ongoing growth.

Cambrex Sale to Premira Funds Affiliate Closes

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

The key is to ensure that excipients only interact with APIs via desired mechanisms.

Managing Excipient Interactions

The new API for hypothyroidism treatment will replace the hormones that are ineffectively produced by the human thyroid gland.

Bioiberica Introduces New API for Hypothyroidism

A new sucrose product from MilliporeSigma has reduced nanoparticle impurities.

Low-Impurity Sucrose Lowers Risk of Protein Instability in Biopharmaceutical Formulation

Gayatri C.Patel, M.Pharm, PhD, is associate professor in the Department of Pharmaceutics & Pharmaceutical Technology, Ramanbhai Patel College of Pharmacy at the Charotar University of Science and Technology, Changa Campus, Changa- 388 421, Anand, Gujarat, India, gayatripatel.ph@charusat.ac.in, +91 2697 265162.

Research examined the effects of varying excipient and polymer weight in coatings designed to optimize the release of diclofenac sodium. The goal was to release it at night to improve the treatment of rheumatoid arthritis. 


Optimizing Compression Coating for Pulsatile Release Tablets

GE Healthcare Life Sciences will supply Akeso Pharmaceuticals with the FlexFactory platform to accelerate production of antibody drugs in the Guangzhou region.

GE Healthcare Life Sciences, Akeso Pharmaceuticals to Accelerate Novel Therapy Manufacturing in China

Several factors must be considered when reformulating APIs for pediatric, geriatric, and other specialty patient populations.

Adapting APIs for Specialty Dosage Forms

On Tuesday Nov. 5, 2019, Dr. Meinolf Brackhagen from DuPont Nutrition & Biosciences will discuss the current and future roles of excipient suppliers

Exploring the Role of Excipient Suppliers

Agnes Shanley is senior editor of Pharmaceutical Technology.

Emphasizing the need for senior management to take cGMP compliance seriously, the agency pointed to “improvisational” validation procedures, lack of compliance with written procedures, as well as  inadequate process control, root cause analysis, and corrective and preventive action (CAPA) in its warning letter.

APIs and Excipients